An immunocompetent rectal cancer model to study radiation therapy

Cell Rep Methods. 2022 Nov 23;2(12):100353. doi: 10.1016/j.crmeth.2022.100353. eCollection 2022 Dec 19.

Abstract

We describe a mouse model of rectal cancer (RC) involving rapid tumor organoid engraftment via orthotopic transplantation in an immunocompetent setting. This approach uses simple mechanical disruption to allow engraftment, avoiding the use of dextran sulfate sodium. The resulting RC tumors invaded from the mucosal surface and metastasized to distant organs. Histologically, the tumors closely resemble human RC and mirror remodeling of the tumor microenvironment in response to radiation. This murine RC model thus recapitulates key aspects of human RC pathogenesis and presents an accessible approach for more physiologically accurate, preclinical efficacy studies.

Keywords: immunocompetent mouse model; radiation; rectal cancer; tumor microenvironment; tumor organoids.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Mice
  • Rectal Neoplasms* / radiotherapy
  • Tumor Microenvironment